CR1 and Alzheimer disease: Recent large genome-wide association studies (GWAS) have reported several novel susceptibility genetic loci for late onset AD, including clusterin (CLU) [9], [10], complement component (3b/4b) receptor 1 (CR1) [10] and the phosphatidylinositol binding clathrin assembly protein (PICALM) [9].